- Home
- FACWW vs NUS Comparison
FACWW vs NUS Comparison
Compare FACWW & NUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FACWW | NUS |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Other Pharmaceuticals |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 231.2M | 256.3M |
| IPO Year | 2025 | 1996 |
Fundamental Metrics
Financial Performance| Metric | FACWW | NUS |
|---|---|---|
| Price | $1.37 | $5.23 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 89.4K | ★ 722.8K |
| Earning Date | N/A | 05-07-2026 |
| Dividend Yield | N/A | ★ 3.36% |
| EPS Growth | N/A | ★ 207.80 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $3,176,718,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $7.14 |
| P/E Ratio | ★ N/A | $128.25 |
| Revenue Growth | N/A | ★ 48.98 |
| 52 Week Low | $1.15 | $4.89 |
| 52 Week High | $2.25 | $14.62 |
Technical Indicators
Market Signals| Indicator | FACWW | NUS |
|---|---|---|
| Relative Strength Index (RSI) | 34.57 | 47.39 |
| Support Level | $1.22 | $5.19 |
| Resistance Level | $1.74 | $5.44 |
| Average True Range (ATR) | 0.34 | 0.21 |
| MACD | -0.01 | 0.06 |
| Stochastic Oscillator | 19.09 | 70.00 |
Price Performance
Historical ComparisonAbout NUS Nu Skin Enterprises Inc.
Nu Skin Enterprises Inc develops and distributes a comprehensive line of beauty and wellness solutions in various countries. The company operates in two primary product categories: beauty and wellness products. Additionally, the company also operates through its subsidiary, Rhyz. It reports revenue from nine segments, consisting of its seven geographic Nu Skin segments: Americas, Southeast Asia/Pacific, Mainland China, Japan, Europe & Africa, South Korea, and Hong Kong/Taiwan and two Rhyz segments: manufacturing, which includes manufacturing and packaging subsidiaries it has acquired; and Rhyz Other, which includes other investments by its Rhyz strategic investment arm. The majority of the company's revenue is generated from the Wellness product category from the Americas segment.